PGD 2 induces eotaxin-3 via PPARγ from sebocytes: A possible pathogenesis of eosinophilic pustular folliculitis

Journal of Allergy and Clinical Immunology

Volumn 129, Issue 2, 2012, Pages 536-543

  Nakahigashi, Kyoko ^a   Doi, Hiromi ^a   Otsuka, Atsushi ^a   Hirabayashi, Tetsuya ^b   Murakami, Makoto ^b   Urade, Yoshihiro ^c   Tanizaki, Hideaki ^a   Egawa, Gyohei ^a   Miyachi, Yoshiki ^a   Kabashima, Kenji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

eotaxin 3 CCL26; hematopoietic prostaglandin D synthase; peroxisome proliferator activated receptor gamma; Prostaglandin D 2; sebocyte

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; EOTAXIN 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN D2; PROSTAGLANDIN SYNTHASE; 13,14 DIHYDRO 15 OXOPROSTAGLANDIN D2; 13,14-DIHYDRO-15-KETOPROSTAGLANDIN D2; 2 CHLORO 5 NITROBENZANILIDE; 2-CHLORO-5-NITROBENZANILIDE; 3 BENZYL 5 (6 CARBOXYHEXYL) 1 (2 CYCLOHEXYL 2 HYDROXYETHYLAMINO)HYDANTOIN; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; ANILIDE; BETA CHEMOKINE; CARBAZOLE DERIVATIVE; CAY 10471; CCL26 PROTEIN, HUMAN; DRUG DERIVATIVE; HYDANTOIN DERIVATIVE; MESSENGER RNA; PROSTAGLANDIN RECEPTOR; SMALL INTERFERING RNA; SULFONAMIDE;

ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; EOSINOPHIL PUSTULAR FOLLICULITIS; FIBROBLAST; FOLLICULITIS; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; KERATINOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SEBACEOUS GLAND; SKIN DEFECT; BULLOUS SKIN DISEASE; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG POTENTIATION; EOSINOPHILIA; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANILIDES; CARBAZOLES; CELL LINE; CELLS, CULTURED; CHEMOKINES, CC; EOSINOPHILIA; EOSINOPHILS; FIBROBLASTS; FOLLICULITIS; HUMANS; HYDANTOINS; KERATINOCYTES; PPAR GAMMA; PROSTAGLANDIN D2; RECEPTORS, PROSTAGLANDIN; RNA, MESSENGER; RNA, SMALL INTERFERING; SEBACEOUS GLANDS; SKIN DISEASES, VESICULOBULLOUS; SULFONAMIDES; TRANSFECTION;

EID: 84856477100     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.11.034     Document Type: Article

References (37)

1. S. Ofuji, F. Furukawa, Y. Miyachi, and S. Ohno Papuloerythroderma Dermatologica 169 1984 125 130
2. K. Kabashima, T. Sakurai, and Y. Miyachi Treatment of eosinophilic pustular folliculitis (Ofuji's disease) with tacrolimus ointment Br J Dermatol 151 2004 949 950
3. K. Sugita, K. Kabashima, C. Koga, and Y. Tokura Eosinophilic pustular folliculitis successfully treated with sequential therapy of interferon-gamma and ciclosporin Clin Exp Dermatol 31 2006 709 710
4. L. Lankerani, and R. Thompson Eosinophilic pustular folliculitis: case report and review of the literature Cutis 86 2010 190 194
5. Y. Teraki, I. Konohana, T. Shiohara, M. Nagashima, and T. Nishikawa Eosinophilic pustular folliculitis (Ofuji's disease): immunohistochemical analysis Arch Dermatol 129 1993 1015 1019
6. M. Fushimi, Y. Tokura, Y. Sachi, H. Hashizume, H. Sudo, and H. Wakita Eosinophilic pustular folliculitis effectively treated with recombinant interferon-gamma: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells Br J Dermatol 134 1996 766 772
7. S. Sano, S. Itami, H. Azukizawa, Y. Araki, M. Higashiyama, and K. Yoshikawa Interleukin 5-inducing activity in the blister fluid of eosinophilic pustular dermatosis Br J Dermatol 141 1999 154 155
8. S.M. Rankin, D.M. Conroy, and T.J. Williams Eotaxin and eosinophil recruitment: implications for human disease Mol Med Today 6 2000 20 27
9. P. Amerio, A. Frezzolini, C. Feliciani, R. Verdolini, P. Teofoli, and O. De Pita Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications Curr Drug Targets Inflamm Allergy 2 2003 81 94
10. Y. Dulkys, G. Schramm, D. Kimmig, S. Knoss, A. Weyergraf, and A. Kapp Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils J Invest Dermatol 116 2001 498 505
11. S. Kagami, H. Saeki, M. Komine, T. Kakinuma, Y. Tsunemi, and K. Nakamura Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells Clin Exp Immunol 141 2005 459 466
12. S. Fukamachi, K. Kabashima, K. Sugita, M. Kobayashi, and Y. Tokura Therapeutic effectiveness of various treatments for eosinophilic pustular folliculitis Acta Derm Venereol 89 2009 155 159
13. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures, properties, and functions Physiol Rev 79 1999 1193 1226
14. K. Kabashima, and Y. Miyachi Prostanoids in the cutaneous immune response J Dermatol Sci 34 2004 177 184
15. T. Honda, Y. Tokura, Y. Miyachi, and K. Kabashima Prostanoid receptors as possible targets for anti-allergic drugs: recent advances in prostanoids on allergy and immunology Curr Drug Targets 11 2010 1605 1613
16. E.M. Sturm, P. Schratl, R. Schuligoi, V. Konya, G.J. Sturm, and I.T. Lippe Prostaglandin E2 inhibits eosinophil trafficking through E-prostanoid 2 receptors J Immunol 181 2008 7273 7283
17. H. Hirai, K. Tanaka, O. Yoshie, K. Ogawa, K. Kenmotsu, and Y. Takamori Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2 J Exp Med 193 2001 255 261
18. Y. Urade, and N. Eguchi Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence Prostaglandins Other Lipid Mediat 68-69 2002 375 382
19. K. Takeda, S. Yokoyama, H. Aburatani, T. Masuda, F. Han, and M. Yoshizawa Lipocalin-type prostaglandin D synthase as a melanocyte marker regulated by MITF Biochem Biophys Res Commun 339 2006 1098 1106
20. Y. Urade, M. Ujihara, Y. Horiguchi, M. Igarashi, A. Nagata, and K. Ikai Mast cells contain spleen-type prostaglandin D synthetase J Biol Chem 265 1990 371 375
21. Y. Kanaoka, and Y. Urade Hematopoietic prostaglandin D synthase Prostaglandins Leukot Essent Fatty Acids 69 2003 163 167
22. C. Shimura, T. Satoh, K. Igawa, K. Aritake, Y. Urade, and M. Nakamura Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin Am J Pathol 176 2011 227 237
23. R.G. Ham Dermal fibroblasts Methods Cell Biol 21A 1980 255 276
24. Y. Boie, N. Sawyer, D.M. Slipetz, K.M. Metters, and M. Abramovitz Molecular cloning and characterization of the human prostanoid DP receptor J Biol Chem 270 1995 18910 18916
25. K. Nagata, and H. Hirai The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes Prostaglandins Leukot Essent Fatty Acids 69 2003 169 177
26. T. Shibata, M. Kondo, T. Osawa, N. Shibata, M. Kobayashi, and K. Uchida 15-Deoxy-delta 12,14-prostaglandin J2: a prostaglandin D2 metabolite generated during inflammatory processes J Biol Chem 277 2002 10459 10466
27. G. Monneret, S. Gravel, M. Diamond, J. Rokach, and W.S. Powell Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor Blood 98 2001 1942 1948
28. T. Satoh, C. Shimura, C. Miyagishi, and H. Yokozeki Indomethacin-induced reduction in CRTH2 in eosinophilic pustular folliculitis (Ofuji's disease): a proposed mechanism of action Acta Derm Venereol 90 2010 18 22
29. H. Fallah, K. Dunlop, and S. Kossard Successful treatment of recalcitrant necrotizing eosinophilic folliculitis using indomethacin and cephalexin Australas J Dermatol 47 2006 281 285
30. C. Tanglertsampan, N. Tantikun, N. Noppakun, and V. Pinyopornpanit Indomethacin for recurrent cutaneous necrotizing eosinophilic vasculitis J Med Assoc Thai 90 2007 1180 1182
31. S.A. Islam, D.S. Chang, R.A. Colvin, M.H. Byrne, M.L. McCully, and B. Moser Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells Nat Immunol 12 2011 167 177
32. I. Nagy, A. Pivarcsi, K. Kis, A. Koreck, L. Bodai, and A. McDowell Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes Microbes Infect 8 2006 2195 2205
33. B.M. Forman, P. Tontonoz, J. Chen, R.P. Brun, B.M. Spiegelman, and R.M. Evans 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma Cell 83 1995 803 812
34. S.A. Kliewer, J.M. Lenhard, T.M. Willson, I. Patel, D.C. Morris, and J.M. Lehmann A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation Cell 83 1995 813 819
35. W. Chen, C.C. Yang, H.M. Sheu, H. Seltmann, and C.C. Zouboulis Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes J Invest Dermatol 121 2003 441 447
36. T. Alestas, R. Ganceviciene, S. Fimmel, K. Muller-Decker, and C.C. Zouboulis Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands J Mol Med 84 2006 75 87
37. E. Makrantonaki, and C.C. Zouboulis Testosterone metabolism to 5-alpha-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes Br J Dermatol 156 2007 428 432